Changes in sputum eosinophils predict loss of asthma control

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 1, 2000, Pages 64-72

  Jatakanon, Anon ^a   Lim, Sam ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; METHACHOLINE; NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; SPIROMETRY; TREATMENT OUTCOME;

EID: 0033956855     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.1.9809100     Document Type: Article

References (32)

1. 1. National Heart, Lung, and Blood Institute. 1997. Guidelines for the diagnosis and management of asthma. National Institutes of Health, Bethesda, MD. NIH Publication No. 97-4051A.
2. 2. British Thoracic Society. 1997. The British guidelines on asthma management. Thorax 52:S1-S21.
3. 3. Sont, J. K., J. Han, J. M. van Krieken, C. E. Evertse, R. Hooijer, L. N. Willems, and P. J. Sterk. 1996. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51:496-502.
4. 4. Claman, D. M., H. A. Boushey, J. Liu, H. Wong, and J. V. Fahy. 1994. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J. Allergy Clin. Immunol. 94:861-869.
5. 5. Pizzichini, M. M., J. C. Kidney, B. J. Wong, M. M. Morris, A. Efthimiadis, J. Dolovich, and F. E. Hargreave. 1996. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Eur. Respir. J. 9:449-455.
6. 6. Keatings, V. M., A. Jatakanon, Y. M. Worsdell, and P. J. Barnes. 1997. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 155:542-548.
7. 7. Pizzichini, M. M., E. Pizzichini, L. Clelland, A. Efthimiadis, J. Mahony, J. Dolovich, and F. E. Hargreave. 1997. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am. J. Respir. Crit. Care Med. 155:1501-1508.
8. 8. Kharitonov, S. A., D. H. Yates, and P. J. Barnes. 1996. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 153:454-457.
9. 9. Kharitonov, S. A., D. H. Yates, K. F. Chung, and P. J. Barnes. 1996. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur. Respir. J. 9:196-201.
10. 10. Gibson, P. G., B. J. Wong, M. J. Hepperle, P. A. Kline, A. Girgis Gabardo, G. Guyatt, J. Dolovich, J. A. Denburg, E. H. Ramsdale, and F. E. Hargreave. 1992. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin. Exp. Allergy 22:525-532.
11. 11. Kharitonov, S. A., K. F. Chung, D. Evans, B. J. O'Connor, and P. J. Barnes. 1996. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am. J. Respir. Crit. Care Med. 153:1773-1780.
12. 12. Kharitonov, S. A., K. Alving, and P. J. Barnes. 1997. Exhaled and nasal nitric oxide measurements: recommendations. Eur. Respir. J. 10:1683-1693.
13. 13. Chai, H., R. S. Farr, L. A. Froehlich, D. A. Mathison, J. A. McLean, R. R. Rosenthal, A. L. Sheffer, S. L. Spector, and R. Townley. 1975. Standardization of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 56:323-327.
14. 14. Enright, P. L., M. D. Lebowitz, and D. W. Cockroft. 1994. Physiologic measures: pulmonary function tests: asthma outcome. Am. J. Respir. Crit. Care Med. 149:S9-S18.
15. 15. Boulet, L. P., H. Turcotte, M. Boutet, L. Montminy, and M. Laviolette. 1993. Influence of natural antigenic exposure on expiratory flows, methacholine responsiveness, and airway inflammation in mild allergic asthma. J. Allergy Clin. Immunol. 91:883-893.
16. 16. Djukanovic, R., I. Feather, C. Gratziou, A. Walls, D. Peroni, P. Bradding, M. Judd, P. H. Howarth, and S. T. Holgate. 1996. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Thorax 51:575-581.
17. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J. Allergy Clin. Immunol. 90:32-42.
18. 18. Spence, D. P., S. L. Johnston, P. M. Calverley, P. Dhillon, C. Higgins, E. Ramhamadany, S. Turner, A. Winning. J. Winter, and S. T. Holgate. 1994. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am. J. Respir. Crit. Care Med. 149:1142-1148.
19. 19. Pizzichini, E., M. M. Pizzichini, A. Efthimiadis, J. Dolovich, and F. E. Hargreave. 1997. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J. Allergy Clin. Immunol. 99:539-544.
20. 20. Kips, J. C., R. A. Peleman, and R. A. Pauwels. 1998. Methods of examining induced sputum: do differences matter? Eur. Respir. J. 11:529-533.
21. 21. Baigelman, W., S. Chodosh, D. Pizzuto, and L. A. Cupples. 1983. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am. J. Med. 75:929-936.
22. 22. Jatakanon, A., S. A. Kharitonov, S. Lim, and P. J. Barnes. 1999. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 54:108-114.
23. 23. Tamaoki, J., M. Kondo, N. Sakai, J. Nakata, H. Takemura, A. Nagai, T. Takizawa, and K. Konno. 1997. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid: The Tokyo Joshi-Idai Asthma Research Group. Am. J. Respir. Crit. Care Med. 155:1235-1240.
24. 24. Kharitonov, S. A., D. Yales, and P. J. Barnes. 1995. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur. Respir. J. 8:295-297.
25. 25. Kikuchi, Y., S. Okabe, G. Tamura, W. Hida, M. Homma, K. Shirato, and T. Takishima. 1994. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N. Engl. J Med. 330:1329-1334.
26. 26. Smith, L. S., and E. R. McFadden, Jr. 1995. Bronchial hyperreactivity revisited. Ann. Allergy 74:454-469.
27. 27. Haahtela, T., M. Jarvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, O. Selroos, A. Sovijarvi, B. Stenius-Aarniala, T. Svahn, R. Tammivaara, and L. A. Laitinen. 1994. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331:700-705.
28. 28. Vathenen, A. S., A. J. Knox, A. Wisniewski, and A. E. Tattersfield. 1991. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am. Rev. Respir. Dis. 143:1317-1321.
29. 29. Fahy, J. V., K. W. Kim, J. Liu, and H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95:843-852.
30. 30. Turner, M. O., P. Hussack, M. R. Sears, J. Dolovich, and F. E. Hargreave. 1995. Exacerbations of asthma without sputum eosinophilia. Thorax 50:1057-1061.
31. 31. Chowienczyk, P. J., D. H. Parkin, C. P. Lawson, and G. M. Cochrane. 1994. Do asthmatic patients correctly record home spirometry measurements? B.M.J. 309:1618.
32. 32. Jatakanon, A., S. Lim, K. F. Chung, and P. J. Barnes. 1998. An inhaled steroid improves markers of airway inflammation in patients with mild asthma. Eur. Respir. J. 12:1084-1088.